Collection of samples, creation of clinical database

A biobank will be prospectively created from patients with lung or colorectal cancer (n=100). Tumor tissue and matched plasma/serum will be collected before initiation of front-line therapy or during routine clinical evaluation. Samples will be kept identifiable, coded or traceable. A database will be formed with patients’ information, i.e., stage of disease, treatment administration, response to treatment and patient survival.